Compliance and Transparency
GEM Biosolutions adheres strictly to applicable local, regional, and international regulations governing the collection and use of human biospecimens. All samples are obtained under approved informed consent protocols and in accordance with internationally recognized ethical standards. Our global network of biorepositories and clinical sites operates under documented, ongoing regulatory oversight, with controls in place to ensure compliance, traceability, and accountability at every stage.
Our Ethical and Regulatory Commitment
-
Compliance with major data protection and privacy regulations, including HIPAA, PIPEDA, GDPR, and applicable country-specific laws.
-
Biospecimen collection conducted under approved informed consent, reviewed by IRBs, Ethics Committees, or Health Ministries, as applicable.
-
Alignment with the Declaration of Helsinki and internationally accepted guidelines governing research involving human subjects.
-
Partnerships with accredited biorepositories and clinical sites worldwide, each operating in compliance with local and regional biobanking and pre-clinical research regulations.
Documentation Available Upon Request
Ethics Committee or Health Ministry approval documentation from partnered providers.
Informed Consent Form (ICF) templates used for approved collections
Provider certifications confirming regulatory and ethical compliance
De-identified medical or pathology reports, when relevant and permitted